Nationwide, an estimated 52 million nonelderly adults live with mental illness, and Medicaid covers nearly one in three (29%) of them, or about 15 million adults. More than 1 in 3 Medicaid enrollees has a mental illness. Mental health treatment rates for Medicaid adults are higher than or similar to those with insurance.
The ability to harness real-world insights at scale empowers life sciences companies and clinicians to develop more targeted therapies, improve patient outcomes, and drive evidence-based innovation in BPH treatment. The post Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia appeared first on MedCity News.
Check out news from Oral Genome, Previor Edge, Onos Health, and more. The post StartUPDATE: New Developments for Healthcare Startups appeared first on MedCity News.
Providence researchers discuss their recently published results on the impact of ambient clinical intelligence on documentation workload
I will be presenting two panels at ISPOR Europe 2024 in Barcelona next week! This year’s conference theme centers on the importance of scientific evidence in understanding and improving the health and well-being of people across the globe. Panel 1: Broader Value Elements: Methods to Quantify Each and Their Relevance for European Markets Monday, Nov…
Physician leader TJ Redington outlines the advantages of CINs for provider leaders
“Reducing denials upfront would improve our revenue, which could be channeled into current and future investments that support our mission.” —Joshua Gayman, Revenue Cycle Manager at UT Medical Center Challenge The University of Tennessee Medical Center (UT Medical Center) is a leading 710-bed acute care hospital with a rich history of exceptional patient care and…
Chiesi Global Rare Diseases is committing up to $115 million to begin a collaboration on Arbor Biotechnologies’ in vivo gene-editing therapy for primary hyperoxaluria type 1, an inherited liver disorder. It’s the rare disease company’s first foray into genetic medicines. The post Chiesi’s Rare Disease Strategy Expands to Genetic Meds via Alliance With CRISPR Startup…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
In this episode, we’re joined by Emily Lindemer, an executive director at Morgan Health. Lindemer discusses a recent report she co-authored, which focuses on maternal health opportunities in employer-sponsored insurance. The post MedCity FemFwd: Comparing Maternal Health in Employer-Sponsored Populations vs. Medicaid appeared first on MedCity News.